Abstract:Background: Domestic and international guidelines recommend endoscopic resection for stage T1 colorectal adenocarcinoma with indications. However, completion surgery remains imperative for patients exhibiting high-risk factors subsequent to endoscopic procedures. Objective: To investigate the evidence, pathological features, and surgical outcomes of completion surgery in patients with T1 colorectal adenocarcinoma following endoscopic resection. Methods: We retrospectively collect data on the clinical features and treatment outcomes of patients with stage T1 colorectal adenocarcinoma who underwent endoscopic resection followed by surgical resection and those who initially completed surgical intervention at Peking University International Hospital between January 2019 and October 2022, with the aim of assessing the necessity and feasibility of surgical intervention. Results: Seventeen patients (Group A) with high-risk factors following endoscopic procedure, especially with deep submucosal invasion and vascular or lymphatic invasion, experienced further surgical resection. The median interval between endoscopic resection and completion surgery was 23.71 days ± 15.89. Sixteen patients (Group B) underwent radical resection without any prior interventions. The surgical approach involves integration of laparoscopy and colonoscopy for precise localization and quantitative diagnosis, followed by radical surgery. The two groups demonstrated significant differences statistically with reference to tumor diameter (1.65 cm ± 0.77 vs 3.36 cm ± 1.39, P = 0.000) and the attainment of standard lymph node count (cases of detected lymph nodes larger than or equal to 12, 5 vs 12, P = 0.015). Postoperative complications and hospital stay manifested no significant disparity statistically in two groups. Patients who underwent completion surgery had no inferior outcomes compared with those who underwent direct surgery in terms of 5-year disease-free survival (Log rank test: P = 0.083, Breslow test: P = 0.089). The two groups also exhibited no significant differences statistically in the context of overall survival (Log rank test: P = 0.652, Breslow test: P = 0.758). Conclusion: Completion surgery is a safe and feasible treatment option for T1 colorectal adenocarcinoma patients with high-risk factors, particularly those with deep submucosal invasion and vascular or lymphatic invasion following endoscopic treatment. Furthermore, subsequent treatment should be chosen based on a comprehensive analysis of the patient's history of abdominal surgery, willingness, and pathological features.

Management of non-curative endoscopic resection of T1 colon cancer

T1 colorectal cancer management in the era of minimally invasive endoscopic resection

Endoscopic Resection of Stage T1 Colorectal Adenocarcinoma Followed by Surgical Intervention: a Single-center Retrospective Study

Approaches and considerations in the endoscopic treatment of T1 colorectal cancer

Long-term outcomes after endoscopic versus surgical resection of T1 colorectal carcinoma

Endoscopic resection of residual rectal neoplasia after definitive chemoradiotherapy for rectal cancer

Management after local excision of small rectal cancers. Indications for completion total mesorectal excision and possible alternatives

Nonoperative Management for Rectal Cancer

Oncological Outcome of T1 Rectal Cancer Undergoing Standard Resection and Local Excision.

Current problems and perspectives of pathological risk factors for lymph node metastasis in T1 colorectal cancer: Systematic review

Current treatment of pT1 rectal cancers in Denmark: A retrospective national cohort study

Long-Term Outcomes of T1 Colorectal Cancer after Endoscopic Resection

T1 colon cancer in the era of screening: risk factors and treatment

Completion Surgery after Non-Curative Local Resection of Early Rectal Cancer

T3N0 Rectal Cancer

Nonoperative management of gastrointestinal malignancies in era of neoadjuvant treatment

Association between pathological T1 colorectal cancer with lymphoid follicular replacement and risk of lymph node metastasis

Pattern of Residual Submucosal Involvement after Neoadjuvant Therapy for Rectal Cancer: A Rationale for the Utility of Endoscopic Submucosal Resection

Clinical outcome of non-curative endoscopic submucosal dissection for early colorectal cancer

Long-Term Survival After Local Excision for T1 Carcinoma of the Rectum

The Risk of Metastatic Recurrence after Non-Curative Endoscopic Resection with Negative Deep Margins for Early Colorectal Cancer: Two-Center Retrospective Cohort Study